购物车
- 全部删除
- 您的购物车当前为空
Anti-PARP1 Antibody (8I163) 是一种 Mouse 抗体,靶向 PARP1。Anti-PARP1 Antibody (8I163) 可用于 IHC-P。
Anti-PARP1 Antibody (8I163) 是一种 Mouse 抗体,靶向 PARP1。Anti-PARP1 Antibody (8I163) 可用于 IHC-P。
产品描述 | Anti-PARP1 Antibody (8I163) is a Mouse antibody targeting PARP1. Anti-PARP1 Antibody (8I163) can be used in IHC-P. |
Ig Type | Monoclonal Mouse IgG2a |
克隆号 | 8I163 |
交叉反应 | Human |
验证活性 | 1. Immunochemical staining of human PARP in human testis with mouse monoclonal antibody at 1:500 dilution, formalin-fixed paraffin embedded sections. 2. Immunochemical staining of human PARP in human placenta with mouse monoclonal antibody at 1:500 dilution, formalin-fixed paraffin embedded sections. |
应用 | IHC-P |
推荐剂量 | IHC-P: 1:200-1:2000 |
抗体种类 | Monoclonal |
宿主来源 | Mouse |
构建方式 | Produced in mouse immunized with E. coli-derived Human PARP / PARP1 fragment. The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography. |
纯化方式 | Protein A |
性状 | Liquid |
缓冲液 | 0.2 μm filtered solution in PBS |
研究背景 | Poly (ADP-ribose) polymerase 1(PRAP1), also known as NAD(+) ADP-ribosyltransferase 1(ADPRT), is a chromatin-associated enzyme that modifies various nuclear proteins by poly(ADP-ribosyl)ation. The ADP-D-ribosyl group of NAD+ is transferred to an acceptor carboxyl group on a histone or the enzyme itself, and further ADP-ribosyl groups are transferred to the 2'-position of the terminal adenosine moiety, building up a polymer with an average chain length of 2-3 units. The poly(ADP-ribosyl)ation modification is critical for a wide range of processes, including DNA repair, regulation of chromosome structure, transcriptional regulation, mitosis and apoptosis. PARP1 is demonstrated to mediate the poly(ADP-ribose) ation of APLF (aprataxin PNK-like factor) and CHFR (checkpoint protein with FHA and RING domains), two representative proteins involved in the DNA damage response and checkpoint regulation. Further, It has been suggested that DNA-dependent protein kinase (DNA-PK), another component of DNA repair, suppresses PARP activity, probably through direct binding and/or sequestration of DNA-ends which serve as an important stimulator for both enzymes. PARP1 inhibitors are thus proposed as a targeted cancer therapy for recombination deficient cancers, such as BRCA2 tumors.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy |
偶联 | Unconjugated |
免疫原 | E. coli-derived Human PARP / PARP1 fragment |
抗原种属 | Human |
研究领域 | Cancer Drug Targets |
储存方式 | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
运输方式 | Shipping with blue ice. |
评论内容